Literature DB >> 15635615

Induced sputum matrix metalloproteinase-9 correlates with lung function and airway inflammation in children with cystic fibrosis.

Scott D Sagel1, Robert K Kapsner, Iris Osberg.   

Abstract

Matrix metalloproteinases (MMPs) degrade extracellular matrix and are implicated in causing airway damage in chronic inflammatory lung diseases, including cystic fibrosis (CF). Our primary objective was to examine the relationship between matrix metalloproteinase-9 (MMP-9) and pulmonary function, as measured by forced expiratory volume in 1 sec (FEV1), in children with CF. We measured MMP-9 and its natural tissue inhibitor of metalloproteinase-1 (TIMP-1) in induced sputum from 18 clinically stable CF children with normal to mildly abnormal lung function and 7 healthy control children. Measures of airway inflammation from induced sputum included cell counts and differentials, interleukin-8 (IL-8), neutrophil elastase, MMP-9, and TIMP-1. Infection was assessed through quantitative bacterial counts. Induced sputum levels of MMP-9 and TIMP-1 were significantly increased in children with CF compared with healthy controls. Also, the MMP-9/TIMP-1 molar ratio was higher in the CF group. Among CF children, there was a significant inverse relationship between MMP-9 and FEV1. In addition, sputum MMP-9 and TIMP-1 concentrations significantly correlated with total white cells and neutrophils, IL-8, and neutrophil elastase. Neither MMP-9 nor TIMP-1 correlated with airway infection. We conclude that clinically stable CF children with normal to mildly abnormal lung function have an increased burden of MMP-9 in their airways. The observed relationships of MMP-9 with lung function and other measures of airway inflammation suggest that this enzyme may be a useful marker of airway injury and airflow obstruction in persons with CF.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15635615     DOI: 10.1002/ppul.20165

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  47 in total

Review 1.  Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted.

Authors:  Kendra J Greenlee; Zena Werb; Farrah Kheradmand
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

2.  Chronic E-Cigarette Use Increases Neutrophil Elastase and Matrix Metalloprotease Levels in the Lung.

Authors:  Arunava Ghosh; Raymond D Coakley; Andrew J Ghio; Marianne S Muhlebach; Charles R Esther; Neil E Alexis; Robert Tarran
Journal:  Am J Respir Crit Care Med       Date:  2019-12-01       Impact factor: 21.405

Review 3.  The matrikine PGP as a potential biomarker in COPD.

Authors:  Mojtaba Abdul Roda; Amanda M Fernstrand; Frank A Redegeld; J Edwin Blalock; Amit Gaggar; Gert Folkerts
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-04-10       Impact factor: 5.464

4.  Impact of azithromycin treatment on macrophage gene expression in subjects with cystic fibrosis.

Authors:  Theodore J Cory; Susan E Birket; Brian S Murphy; Don Hayes; Michael I Anstead; Jamshed F Kanga; Robert J Kuhn; Heather M Bush; David J Feola
Journal:  J Cyst Fibros       Date:  2013-09-07       Impact factor: 5.482

5.  Whole-blood transcriptomic responses to lumacaftor/ivacaftor therapy in cystic fibrosis.

Authors:  Benjamin T Kopp; James Fitch; Lisa Jaramillo; Chandra L Shrestha; Frank Robledo-Avila; Shuzhong Zhang; Sabrina Palacios; Fred Woodley; Don Hayes; Santiago Partida-Sanchez; Octavio Ramilo; Peter White; Asuncion Mejias
Journal:  J Cyst Fibros       Date:  2019-08-29       Impact factor: 5.482

6.  IL-23 mediates inflammatory responses to mucoid Pseudomonas aeruginosa lung infection in mice.

Authors:  Patricia J Dubin; Jay K Kolls
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-10-27       Impact factor: 5.464

7.  Sputum biomarkers of inflammation and lung function decline in children with cystic fibrosis.

Authors:  Scott D Sagel; Brandie D Wagner; Margaret M Anthony; Peggy Emmett; Edith T Zemanick
Journal:  Am J Respir Crit Care Med       Date:  2012-08-16       Impact factor: 21.405

8.  Antiproteases as therapeutics to target inflammation in cystic fibrosis.

Authors:  Derek J Quinn; Sinéad Weldon; Clifford C Taggart
Journal:  Open Respir Med J       Date:  2010-03-30

9.  Matrix metalloproteinase activity in pediatric acute lung injury.

Authors:  Michele Y F Kong; Amit Gaggar; Yao Li; Margaret Winkler; J Edwin Blalock; J P Clancy
Journal:  Int J Med Sci       Date:  2008-12-16       Impact factor: 3.738

10.  Azithromycin treatment alters gene expression in inflammatory, lipid metabolism, and cell cycle pathways in well-differentiated human airway epithelia.

Authors:  Carla Maria P Ribeiro; Harry Hurd; Yichao Wu; Mary E B Martino; Lisa Jones; Brian Brighton; Richard C Boucher; Wanda K O'Neal
Journal:  PLoS One       Date:  2009-06-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.